We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Surgery No Help for Mild Knee Osteoarthritis

By HospiMedica International staff writers
Posted on 10 Sep 2014
Print article
Arthroscopic surgery for degenerative meniscal tears in patients with mild knee osteoarthritis (OA) had no benefit for function or pain, according to a new study.

Researchers at McMaster University (Hamilton, ON, Canada) searched MEDLINE, Embase, and the Cochrane databases for randomized controlled trials (RCTs) published from 1946 to 2014. Two reviewers independently screened all titles and abstracts for eligibility, and assessed risk of bias for all included studies and pooled outcomes using a random-effects model. In all, seven RCTs involving 805 patients were included in the review.

The results showed that the pooled treatment effect of arthroscopic surgery did not show a significant or minimally important difference (MID) between treatment arms for long-term functional outcomes. Short-term functional outcomes between groups were significant, but did not exceed the threshold for MID. The researchers also found that arthroscopic surgery did not result in a significant improvement in pain scores in the short term or in the long term. The study was published on August 25, 2014, in CMAJ.

“Arthroscopic debridement or washout of knee osteoarthritis has come under lots of scrutiny, based upon trials that suggest patients get no benefit from the procedure. We're concerned that many surgeons worldwide may still be doing this procedure,” said senior author Mohit Bhandari, MD, PhD. “In the context of limited healthcare resources, clinicians must carefully select patients with degenerative meniscal pathology who would benefit from surgical intervention. The results of this meta-analysis suggest that an initial trial of non-operative interventions should play a large role for middle-aged patients.”

OA is a group of mechanical abnormalities involving degradation of joints, including the articular cartilage and subchondral bone. Symptoms may include joint pain, tenderness, stiffness, locking, and sometimes an effusion. A variety of causes—hereditary, developmental, metabolic, and mechanical deficits—may initiate processes leading to loss of cartilage. As a result of decreased movement secondary to pain, regional muscles may atrophy, and ligaments may become more lax. OA of the knee affects approximately 250 million people worldwide (3.6% of the population).

MID is defined as the smallest effect that an informed patient would perceive as valuable enough to justify a change in therapeutic management, when weighing the anticipated benefits against the possible harms of an intervention.

Related Links:

McMaster University


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Silver Member
ECG Management System
NEMS-Q

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.